Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP Research & Development
-
Stock Symbol
-
CYTK on Nasdaq
Fady Ibraham Malik - trading volume in the past year for Cytokinetics Inc
Holdings reported by Fady Ibraham Malik for Cytokinetics Inc
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
140K |
$5.07M |
$36.18 |
Apr 8, 2025 |
Direct |
|
|
| Incentive Stock Option (Right to Buy) |
2.29K |
$86.3K |
$37.63 |
Mar 14, 2025 |
Direct |
Common Stock |
|
| Non-Qualified Stock Option (Right to Buy) |
58.3K |
$0 |
$41.69 |
Jul 9, 2024 |
Direct |
Common Stock |
|
| Non-Qualified Stock Option (Right to Buy) |
27.1K |
|
|
Apr 8, 2025 |
Direct |
Common Stock |
|
Transactions reported by Fady Ibraham Malik for Cytokinetics Inc
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.